Advertisement

Journal of Cancer Education

, Volume 28, Issue 3, pp 454–457 | Cite as

Mini-review on Glycolysis and Cancer

  • M. Akram
Article

Abstract

Glycolysis is a universal pathway in the living cells. The complete pathway of glycolysis was elucidated in 1940. This pathway is often referred to as Embden–Meyerhof pathway in honor of the two biochemists that made a major contribution to the knowledge of glycolysis. The objective of the study was to review the published literature on glycolysis and relation to cancer. The material for this review was taken mostly from up-to-date biochemistry textbooks and electronic journals. To collect publications, PubMed and the Cochrane database of systematic reviews were used. Some other relevant references were collected from personal database of papers on glycolysis and cancer. Several glycolytic inhibitors are currently in preclinical and clinical development. Inhibition of glycolysis in cancer cells is a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. This article is an important topic to be considered by cancer researchers and those who treat cancers.

Keywords

Glycolysis Cancer Research study Literature review 

References

  1. 1.
    Bacci G, Capanna R, Orlandi M (1985) Prognostic significance of serum lactic acid dehydrogenase in Ewing’s tumor of bone. Ric Clin Lab 15:89–96PubMedGoogle Scholar
  2. 2.
    Veramendi J, Fernie AR, Leisse A, Willmitzer L, Trethewey RN (2002) Potato hexokinase 2 complements transgenic Arabidopsis plants deficient in hexokinase 1 but does not play a key role in tuber carbohydrate metabolism. Plant Mol Biol 49:491–501PubMedCrossRefGoogle Scholar
  3. 3.
    Tang GQ, Hardin SC, Dewey R, Huber SC (2003) A novel C-terminal proteolytic processing of cytosolic pyruvate kinase, its phosphorylation and degradation by the proteasome in developing soybean seeds. Plant J 34:77–93PubMedCrossRefGoogle Scholar
  4. 4.
    Goldblatt H, Cameron C (1953) Induced malignancy in cells from rat myocardium subjected to intermittent anaerobiosis during long propagation in vitro. J Exp Med 97:525–552PubMedCrossRefGoogle Scholar
  5. 5.
    Druml W, Kleinberger G, Neumann E, Pichler M, Gassner A (1981) [Acute leukemia associated with lactic acidosis] [article in German]. Schweiz Med. Wochenschr 111:146–150Google Scholar
  6. 6.
    Allard MF, Schönekess BO, Henning SL, English DR, Lopaschuk GD (2008) Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. Am J Physiol 267(2):742–750Google Scholar
  7. 7.
    Pérez-Rodríguez J, Sánchez-Jiménez F, Márquez FJ, Medina MA, Quesada AR, Núñez de Castro I (1987) Malate-citrate cycle during glycolysis and glutaminolysis in Ehrlich ascites tumor cells. Biochimie 69(5):469–474PubMedCrossRefGoogle Scholar
  8. 8.
    Warburg O (1910) The metabolism of tumours. J Physiol Chem 56:66–305Google Scholar
  9. 9.
    Lu H, Forbes RA, Verma A (2002) Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277:23111–23115PubMedCrossRefGoogle Scholar
  10. 10.
    Schwickert G, Walenta S, Sundfør K, Rofstad EK, Mueller-Klieser W (1995) Correlation of high lactate levels in human cervical cancer with incidence of metastasis. Cancer Res 55:4757–4759PubMedGoogle Scholar
  11. 11.
    Sun RC, Fadia M, Dahlstrom JE, Parish CR, Board PG, Blackburn AC (2009) Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo. Breast Cancer Res Treat 120(1):253–260PubMedCrossRefGoogle Scholar
  12. 12.
    Xu RH, Pelicano H, Zhou Y, Carew JS, Feng L, Bhalla KN, Keating MJ, Huang P (2005) Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 65(2):613–621PubMedGoogle Scholar
  13. 13.
    Altenberg B, Greulich KO (2008) Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 84(6):1014–1020CrossRefGoogle Scholar
  14. 14.
    Broadley K, Larsen L, Herst PM, Smith RA, Berridge MV, McConnell MJ (2011) The novel phloroglucinol PMT7 kills glycolytic cancer cells by blocking autophagy and sensitizing to nutrient stress. J Cell Biochem 112(7):1869–1879PubMedCrossRefGoogle Scholar
  15. 15.
    Fantin VR, St-Pierre J, Leder P (2006) Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell 9(6):425–434PubMedCrossRefGoogle Scholar
  16. 16.
    Ha TK, Her NG, Lee MG, Ryu BK, Lee JH, Han J, Jeong SI, Kang MJ, Kim NH, Kim HJ, Chi SG (2012) Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription. Cancer Res 72(16):4097–4109PubMedCrossRefGoogle Scholar
  17. 17.
    Scatena R, Bottoni P, Pontoglio A, Mastrototaro L, Giardina B (2002) Glycolytic enzyme inhibitors in cancer treatment. Expert Opin Investig Drugs 17(10):1533–1545CrossRefGoogle Scholar
  18. 18.
    Fang R, Xiao T, Fang Z, Sun Y, Li F, Gao Y, Feng Y, Li L, Wang Y, Liu X, Chen H, Liu XY, Ji H (2012) MicroRNA-143 (miR-143) regulates cancer glycolysis via targeting hexokinase 2 gene. J Biol Chem 287(27):23227–2335PubMedCrossRefGoogle Scholar
  19. 19.
    Granchi C, Minutolo F (2012) Anticancer agents that counteract tumor glycolysis. ChemMedChem 7(8):1318–1350PubMedCrossRefGoogle Scholar
  20. 20.
    Sukhatme VP, Chan B (2012) Glycolytic cancer cells lacking 6-phosphogluconate dehydrogenase metabolize glucose to induce senescence. FEBS Lett 586(16):2389–2395PubMedCrossRefGoogle Scholar
  21. 21.
    Wang MD, Shi YF, Wang H, Wang JL, Ma WB, Wang RZ. Virtual mutagenesis of isocitrate dehydrogenase 1 involved in glioblastoma multiforme. Chin Med J 124(17):2611–2615)Google Scholar
  22. 22.
    Koebmann BJ, Westerhoff HV, Snoep JL, Nilsson D, Jensen PR (2002) The glycolytic flux in Escherichia coli is controlled by the demand for ATP. J Bacteriol 184:3909–3916PubMedCrossRefGoogle Scholar
  23. 23.
    Guyton A, Hall J (1996) Textbook of medical physiology, 9th edn. W.B. Saunders, Philadelphia, PA, pp 868–870Google Scholar
  24. 24.
    Fernie AR, Roscher A, Ratcliffe RG, Kruger NJ (2011) Fructose 2,6-bisphosphate activates pyrophosphate: fructose 6-phosphate 1-phosphotransferase and increases triose phosphate to hexose phosphate cycling in heterotrophic cells. Planta 212:250–263CrossRefGoogle Scholar
  25. 25.
    Mulquiney PJ, Bubb WA, Kuchel PW. Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: in vivo kinetic characterization of 2,3-bisphosphoglycerate synthase/phosphatase using 13C and 31P NMR. Biochem J 342 (3):567–580Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Eastern Medicine and Surgery, Faculty of Medical and Health SciencesThe University of PoonchAzad Jammu and KashmirPakistan

Personalised recommendations